Information
-
Trademark
-
90392963
-
International Classifications
-
Filing Date
December 18, 2020
3 years ago
-
Transaction Date
April 03, 2024
5 months ago
-
Status Date
April 02, 2024
5 months ago
-
Published for Opposition Date
August 10, 2021
3 years ago
-
Location Date
October 05, 2021
2 years ago
-
Status Code
734
-
Current Location
INTENT TO USE SECTION
Employee Name
MASULLO, MARCO
-
Attorney Docket Number
U2400-00072
Attorney Name
Nicole K. McLaughlin
Law Office Assigned Location Code
N50
-
Owners
Mark Drawing Code
4000
Mark Identification
GALENAGEN
Case File Statements
- GS0051: Pharmaceutical preparations and substances for the diagnosis, treatment and prevention of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; pharmaceutical preparations for the treatment and prevention of Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; Antibacterial, antiviral and antifungal preparations for skin and wound healing; disinfectants and antiseptics; antimicrobial cleansers for sanitation purposes; Medical assays for testing of bodily fluids and tissues for testing of enzymes in humans; biological preparations for medical testing; diagnostic preparations for medical purposes; testing kits comprised of medical diagnostic reagents and assays for testing enzymes and body fluids for use in disease detection; medical diagnostic reagents and assays for testing of enzymes and body fluids; chemical preparations for medical testing; diagnostic biomarker reagents for medical testing; all the foregoing for the diagnosis and treatment of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders
- GS0441: Medical testing for diagnostic and treatment purposes; Medical consultations; medical testing for diagnostic treatment purposes in the fields of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; medical testing for diagnostic treatment and prevention of Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; Medical diagnostic testing, monitoring and reporting services; performing diagnosis of diseases; Health care services, namely, the administration of medical assays for the detection of enzymes in humans
- GS0421: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and pharmaceutical research; Development of pharmaceuticals and medical devices for others; Providing temporary use of non-downloadable computer software that allows users to make determinations regarding neurological diseases, specifically baseline staging, data gathering and monitoring of early, middle and late stage neurological diseases; Design and development of medical assays for others; clinical research and development of treatments for viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; clinical research and development of treatments for the treatment and prevention of Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; clinical research and development of treatments for antibacterial, antiviral, and antifungal preparations for skin and wound healing; clinical research and development of disinfectants, antiseptics and antimicrobial cleansers for sanitation purposes; medical and scientific research services in the field of digestion and detection of enzymes or biological substances in the body
Case File Event Statements
-
4/3/2024 - 5 months ago
28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
4/2/2024 - 5 months ago
27 - SOU EXTENSION 5 GRANTED
Type: EX5G
-
4/2/2024 - 5 months ago
26 - SOU EXTENSION 5 FILED
Type: EXT5
-
4/2/2024 - 5 months ago
25 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
10/4/2023 - 11 months ago
24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
10/2/2023 - 11 months ago
23 - SOU EXTENSION 4 GRANTED
Type: EX4G
-
10/2/2023 - 11 months ago
22 - SOU EXTENSION 4 FILED
Type: EXT4
-
10/2/2023 - 11 months ago
21 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
3/31/2023 - a year ago
20 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
3/29/2023 - a year ago
19 - SOU EXTENSION 3 GRANTED
Type: EX3G
-
3/29/2023 - a year ago
18 - SOU EXTENSION 3 FILED
Type: EXT3
-
3/29/2023 - a year ago
17 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
10/4/2022 - a year ago
16 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
9/30/2022 - a year ago
15 - SOU EXTENSION 2 GRANTED
Type: EX2G
-
9/30/2022 - a year ago
14 - SOU EXTENSION 2 FILED
Type: EXT2
-
9/30/2022 - a year ago
13 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
3/30/2022 - 2 years ago
12 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
3/28/2022 - 2 years ago
11 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
3/28/2022 - 2 years ago
10 - SOU EXTENSION 1 FILED
Type: EXT1
-
3/28/2022 - 2 years ago
9 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
10/5/2021 - 2 years ago
8 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
8/10/2021 - 3 years ago
7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
8/10/2021 - 3 years ago
6 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
7/21/2021 - 3 years ago
5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
7/8/2021 - 3 years ago
4 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
6/14/2021 - 3 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/1/2021 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
12/22/2020 - 3 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP